Fresenius Medical Care Ag & CO Kgaa (FME.D.DX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 1,785,899 | 1,593,160 | 724,847 | 735,479 | 737,800 |
| Income taxes - deferred | 111,104 | 64,266 | 89,171 | -203,046 | -5,351 |
| Accounts receivable | 71,695 | -64,111 | -170,490 | -86,247 | -305,918 |
| Accounts payable and accrued liabilities | 1,373,617 | -164,767 | 368,390 | 518,741 | 170,564 |
| Other Working Capital | 1,235,463 | -12,447 | 460,514 | 1,209,853 | -141,235 |
| Other Operating Activity | -344,622 | 1,150,850 | 589,479 | 17,031 | 1,578,826 |
| Operating Cash Flow | $4,233,156 | $2,566,951 | $2,061,911 | $2,191,811 | $2,034,685 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,036,405 | -1,113,256 | -1,002,747 | -841,235 | -962,564 |
| Net Acquisitions | -244,377 | -2,172,731 | 757,708 | -150,306 | -348,955 |
| Purchase Of Investment | -96,401 | N/A | N/A | N/A | N/A |
| Sale Of Investment | 42,241 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-1,334,942 | $-3,285,987 | $-245,039 | $-991,541 | $-1,311,519 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -1,096,879 | -237,509 | 624,744 | 208,687 | 471,709 |
| Debt Issued | 2,120,905 | 3,460,805 | 612,388 | 582,311 | 2,179 |
| Debt Repayment | -2,290,017 | -2,904,748 | -1,076,204 | -1,099,329 | -696,846 |
| Common Stock Repurchased | -365,988 | -599,796 | -37,221 | -57,938 | N/A |
| Dividend Paid | -351,170 | -354,636 | -324,838 | -293,973 | -263,550 |
| Other Financing Activity | -680,878 | 169,251 | -480,605 | -138,388 | -69,506 |
| Financing Cash Flow | $-2,664,027 | $-466,633 | $-681,736 | $-798,630 | $-556,014 |
| Exchange Rate Effect | -160,371 | 47,760 | 32,387 | -132,413 | 20,860 |
| Beginning Cash Position | 1,007,723 | 2,145,632 | 978,109 | 708,882 | 522,487 |
| End Cash Position | 1,081,539 | 1,007,723 | 2,145,632 | 978,109 | 710,499 |
| Net Cash Flow | $234,187 | $-1,185,669 | $1,135,136 | $401,640 | $167,152 |
| Free Cash Flow | |||||
| Operating Cash Flow | 4,233,156 | 2,566,951 | 2,061,911 | 2,191,811 | 2,034,685 |
| Capital Expenditure | -1,051,983 | -1,124,791 | -1,057,276 | -944,460 | -979,358 |
| Free Cash Flow | 3,181,173 | 1,442,160 | 1,004,635 | 1,247,351 | 1,055,328 |